REDUCTION IN THE RATE OF EGFR DECLINE WITH SEMAGLUTIDE VS PLACEBO: A POST HOC POOLED ANALYSIS OF SUSTAIN 6 AND PIONEER 6

被引：0
|
作者：
Tuttle, Katherine [1 ,2 ]
Cherney, David [3 ]
Hadjadj, Samy [4 ]
Idorn, Thomas [5 ]
Mosenzon, Ofri [6 ]
Perkovic, Vlado [7 ]
Rasmussen, Soren [5 ]
Wolthers, Benjamin [5 ]
Bain, Stephen C. [8 ]
机构：
[1] Univ Washington, PMRC, Inst Translat Hlth Sci, Spokane, WA USA
[2] Nephrol Div, Spokane, WA USA
[3] Toronto Gen Hosp, Div Nephrol, Dept Med, Toronto, ON, Canada
[4] Univ Nantes, CNRS, CHU Nantes, Inst Thorax,INSERM, Nantes, France
[5] Novo Nordisk, Soborg, Denmark
[6] Hadassah Hebrew Univ Hosp, Diabet Clin Res Ctr, Jerusalem, Israel
[7] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[8] Swansea Univ, Diabet Res Unit Cymru, Sch Med, Swansea, W Glam, Wales
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
TO002
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [21] CHANGE IN KDIGO KIDNEY RISK CATEGORY WITH SEMAGLUTIDE TREATMENT-A POST HOC ANALYSIS OF THE SUSTAIN 6 TRIAL
    Tuttle, Katherine
    Bain, Stephen C.
    Cherney, David
    Lawson, Jack
    Rasmussen, Soren
    Vrhnjak, Blaz
    Khunti, Kamlesh
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I331 - I331
  • [22] The effect of semaglutide once weekly on MACE and blood pressure by race and ethnicity: SUSTAIN 6 post hoc analysis
    Desouza, C.
    Bain, S. C.
    Gondolf, T.
    Hansen, T.
    Holst, I.
    Rea, R. R.
    Seufert, J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3876 - 3876
  • [23] Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
    Verma, Subodh
    Bain, Stephen C.
    Fries, Tea Monk
    Mazer, C. David
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Saevereid, Hans A.
    Zinman, Bernard
    Buse, John B.
    DIABETES OBESITY & METABOLISM, 2019, 21 (07): : 1745 - 1751
  • [24] Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide
    Verma, Subodh
    Fainberg, Udi
    Husain, Mansoor
    Rasmussen, Soren
    Ryden, Lars
    Ripa, Maria Sejersten
    Buse, John B.
    DIABETES OBESITY & METABOLISM, 2021, 23 (07): : 1677 - 1680
  • [25] Glycaemic variability of oral semaglutide vs empagliflozin: a post-hoc analysis of PIONEER 2
    Montanya, E.
    Abildlund, M. T.
    Kreiner, E. B.
    Mosenzon, O.
    Rosenlund, S.
    Vilsboll, T.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 257 - 257
  • [26] DURATION OF DIABETES AND CARDIORENAL EFFICACY OF LIRAGLUTIDE AND SEMAGLUTIDE: A POST HOC ANALYSIS OF THE LEADER AND SUSTAIN-6 CLINICAL TRIALS
    Verma, Subodh
    Bain, Stephen C.
    Honore, Julie Broe
    Fries, Tea Monk
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Zinman, Bernard
    Buse, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1704 - 1704
  • [27] Consistent Kidney Benefits With Semaglutide vs. Placebo Regardless of Baseline Urine Albumin Creatinine Ratio in Subjects With Type 2 Diabetes at High Cardiovascular Risk: A Post Hoc Analysis of SUSTAIN 6
    Heerspink, Hiddo J. L.
    Kuhlman, Anja B.
    Mann, Johannes F.
    Rasmussen, Soren
    Rossing, Peter
    Vrhnjak, Blaz
    Cherney, David
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 676 - 676
  • [28] The effect of once-weekly semaglutide on MACE, blood pressure and lipids by race and ethnicity: a SUSTAIN 6 post hoc analysis
    Bain, S. C.
    Desouza, C. V.
    Gondolf, T.
    Hansen, T.
    Holst, I.
    Rea, R. R.
    Seufert, J.
    DIABETOLOGIA, 2019, 62 : S365 - S365
  • [29] SUSTAIN 6: A POST-HOC ANALYSIS OF THE EFFECT OF SEMAGLUTIDE ON CARDIOVASCULAR OUTCOMES OVER TIME IN SUBJECTS WITH TYPE 2 DIABETES
    Bellary, S.
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. Gaarsdal
    Leiter, L.
    ATHEROSCLEROSIS SUPPLEMENTS, 2018, 34 : E6 - E7
  • [30] Effect of once-weekly semaglutide on insulin use in subjects with type 2 diabetes: a post hoc analysis of SUSTAIN 6
    Seufert, J.
    Desouza, C.
    Kirk, A. R.
    Lawson, J.
    Lingvay, I.
    Sondergaard, A. L.
    Bain, S. C.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 251 - 252
12345